| PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
| RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |
| FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
| FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
| FLII |
Q13045
|
FLII actin remodeling protein
|
|
5.5E-12 |
0.520 |
0.808 |
| XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
| RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
| DEAF1 |
O75398
|
DEAF1 transcription factor
|
|
3.4E-04 |
0.575 |
0.615 |
| IQSEC2 |
Q5JU85
|
IQ motif and Sec7 domain ArfGEF 2
|
|
1.00 |
0.573 |
0.577 |
| FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
| FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |
| MAD2L2 |
Q9UI95
|
mitotic arrest deficient 2 like 2
|
|
8.2E-02 |
0.547 |
0.731 |
| FANCE |
Q9HB96
|
FA complementation group E
|
|
1.5E-06 |
0.553 |
0.808 |
| RAB3GAP1 |
Q15042
|
RAB3 GTPase activating protein catalytic subunit 1
|
|
1.5E-07 |
0.566 |
0.692 |
| UBE2T |
Q9NPD8
|
ubiquitin conjugating enzyme E2 T
|
|
1.1E-05 |
0.550 |
0.731 |
| FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
| SLX4 |
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
1.6E-22 |
0.565 |
0.731 |
| RAB18 |
Q9NP72
|
RAB18, member RAS oncogene family
|
|
0.91 |
0.582 |
0.692 |
| TBC1D20 |
Q96BZ9
|
TBC1 domain family member 20
|
|
0.93 |
0.621 |
0.500 |
| MCTP2 |
Q6DN12
|
multiple C2 and transmembrane domain containing 2
|
|
6.0E-52 |
0.623 |
0.577 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| ERCC4 |
Q92889
|
ERCC excision repair 4, endonuclease catalytic subunit
|
Enzyme
|
1.4E-12 |
0.468 |
0.846 |